( SEVAMED 2003)

(Diagnosis, Diagnostics, Immunodiagnosis, Immunodiagnostics, Pathogenesis, Vaccines & Drugs)

Click Here for Abstract

Back To Content Page

January 2003  

6044.         Melrose WD. Lymphatic filariasis: new insights into an old disease. Int J Parasitol. 2002 Jul;32(8):947-60. Review.

6045.         Sehri P, Krishnanand G, Gupta A, Mukherjee A. Breast filariasis. Indian J Path Microbiol. 200; 43(3): 363-4.


6046.         Etya'ale D. Eliminating onchocerciasis as a public health problem: the beginning of the end. Br J Ophthalmol. 2002 Aug;86(8):844-6.

6047.         Sharma DC. New goals set for filariasis elimination in India. Lancet Infect Dis. 2002 Jul;2(7):389.

6048.       Unnasch TR. River blindness. Lancet. 2002 Jul 20;360(9328):182-3.


            April 2003

6672.      Arya SC.An enzyme-linked immunosorbent assay (ELISA) format to diagnose Wuchereria bancrofti specific immunoglobulin G4 class in urine samples.Am J Trop Med Hyg  2002 Oct;67(4):335

6673.      Birley H, Duerden B, Hart CA, Curless E, Hay PE, Ison CA, Renton AM, Richens J, Wyatt GB.Sexually transmitted diseases: microbiology and management.J Med Microbiol  2002 Oct;51(10):793-807

6674.      Bregani ER, Ghiringhelli C, Ceraldi T, Rovellini A. Identification of Mansonella perstans microfilariae in ascitic fluid.Trop Doct  2002 Oct;32(4):249-50

6675.      Dash PK; Mishra GC; Pattanaik MR; Mohapatra N; Behera G. Clinical profile of tropical pulmonary eosinophilia with special reference to bronchoalveolar lavage  Antiseptic. 2002 Sep; 99(9): 332-4

6676.      Kipp W, Bamhuhiiga J. Onchodermal skin disease in a hyperendemic onchocerciasis focus in western Uganda. Am J Trop Med Hyg  2002 Nov;67(5):475-9

6677.      Kundu AK, Giri A, Ghosh G, Saha SR.Microfilaria in a thyroid nodule which resolved on treatment. Trop Doct  2002 Oct;32(4):248

6678.      R. Alli, B. Bhunia, GP Chhotray, MVR Reddy, BC Harinath. Microscopic haematuria as an occult filarial infection in Bhubaneshwar an endemic area for bancroftian filariasis. Indian J of Clin Biochem 2003, 18 (1): 61-64.

6679.      Stringfellow GJ, Francis IC, Coroneo MT, Walker J.Orbital dirofilariasis. Clin Experiment Ophthalmol  2002 Oct;30(5):378-80

6679.Supali T, Ismid IS, Ruckert P, Fischer P. Treatment of Brugia timori and Wuchereria bancrofti infections in Indonesia using DEC or a combination of DEC and albendazole: adverse reactions and short-term effects on microfilariae.Trop Med Int Health  2002 Oct;7(10):894-901


6680.      Bockarie MJ, Tisch DJ, Kastens W, Alexander ND, Dimber Z, Bockarie F, Ibam E, Alpers MP, Kazura JW. Mass treatment to eliminate filariasis in Papua New Guinea.N Engl J Med  2002 Dec 5;347(23):1841-8

6681.      Cooper PJ, Schwartz LB, Irani AM, Awadzi K, Guderian RH, Nutman TB. Association of transient dermal mastocytosis and elevated plasma tryptase levels with development of adverse reactions after treatment of onchocerciasis with ivermectin. J Infect Dis  2002 Nov 1;186(9):1307-13

6682.      Doan NM, Keiser PB, Bates RA, Fedorko DP, Weina PJ, Lucey DR. A 33-year-old woman from Nigeria with eosinophilia. Clin Infect Dis  2002 Nov 15;35(10):1204, 1263-4

6683.      Duke BO, Marty AM, Peett DL, Gardo J, Pion SD, Kamgno J, Boussinesq M. Neoplastic change in Onchocerca volvulus and its relation to ivermectin treatment. Parasitology  2002 Nov;125(Pt 5):431-44

6684.      McCarroll L, Hemingway J.Can insecticide resistance status affect parasite transmission in mosquitoes? Insect Biochem Mol Biol  2002 Oct;32(10):1345-51

6685.      Roberts L.Mosquitoes and disease. Science  2002 Oct 4;298(5591):82-3

6686.      Shriram AN, Murhekar MV, Ramaiah KD, Sehgal SC. Prevalence of diurnally subperiodic bancroftian filariasis among the Nicobarese in Andaman and Nicobar Islands, India: effect of age and gender. Trop Med Int Health  2002 Nov;7(11):949-54


6687.      Onwujekwe O, Chima R, Shu E, Okonkwo P. Community-directed treatment with ivermectin in two Nigerian communities: an analysis of first year start-up processes, costs and consequences. Health Policy  2002 Oct;62(1):31-51

6688.      Ottesen EA. Major progress toward eliminating lymphatic filariasis. N Engl J Med  2002 Dec 5;347(23):1885-6 

6689.      Rajendran R, Sunish IP, Mani TR, Munirathinam A, Satyanarayana K. Targeting of children in filariasis mass drug administration. Lancet  2002 Nov 2;360(9343):1430


July 2003 

7198.   Ali MM, Baraka OZ, AbdelRahman SI, Sulaiman SM, Williams JF, Homeida MM, Mackenzie CD. Immune responses directed against microfilariae correlate with severity of clinical onchodermatitis and treatment history. J Infect Dis  2003 Feb 15;187(4):714-7

7199.   Belizario VY, Amarillo ME, de Leon WU, de los Reyes AE, Bugayong MG, Macatangay BJ. A comparison of the efficacy of single doses of albendazole, ivermectin, and diethylcarbamazine alone or in combinations against Ascaris and Trichuris spp. Bull World Health Organ  2003;81(1):35-42 

7200.   Bhunia B, Bhandari YP, Reddy MVR, Harinath BC. Analysis of IgG subclasses and IgE antibodies across the clinical spectrum of bancroftian filariasis in an endemic area. Indian J Patho Microbiol 2003; Vol 46(1):113-117.

7201.   Engelbrecht F, Oettl T, Herter U, Link C, Philipp D, Edeghere H, Kaliraj P, Enwezor F. Analysis of Wuchereria bancrofti infections in a village community in northern Nigeria: increased prevalence in individuals infected with Onchocerca volvulus. Parasitol Int  2003 Mar;52(1):13-20

7202.   Rahmah N, Lim BH, Azian H, Ramelah TS, Rohana AR.  Short communication: use of a recombinant antigen-based ELISA to determine prevalence of brugian filariasis among Malaysian schoolchildren near Pasir Mas, Kelantan-Thailand border. Trop Med Int Health  2003 Feb;8(2):158-63 

7203.   Terhell AJ, Haarbrink M, van den Biggelaar A, Mangali A, Sartono E, Yazdanbakhsh M. Long-term follow-up of treatment with diethylcarbamazine on anti-filarial IgG4: dosage, compliance, and differential patterns in adults and children. Am J Trop Med Hyg  2003 Jan;68(1):33-9 

7204.   Zhang X, Ye ZQ, Chen Z, Chen ZQ, Zhu QG, Xin M, Li LC. Comparison of open surgery versus retroperitoneoscopic approach to chyluria. J Urol  2003 Mar;169(3):991-3 


7205.   Chadee DD, Rawlins SC, Tiwari TS.  Short communication: concomitant malaria and filariasis infections in Georgetown, Guyana. Trop Med Int Health. 2003 Feb;8(2):140-3.

7206.   Guevara AG, Vieira JC, Lilley BG, Lopez A, Vieira N, Rumbea J, Collins R, Katholi CR, Unnasch TR.  Entomological evaluation by pool screen polymerase chain reaction of Onchocerca volvulus transmission in Ecuador following mass Mectizan distribution. Am J Trop Med Hyg. 2003 Feb;68(2):222-7.

7207.   Hoerauf A, Buttner DW, Adjei O, Pearlman E.  Onchocerciasis. BMJ. 2003 Jan 25;326(7382):207-10.

7208.   Lobos E, Nutman TB, Hothersall JS, Moncada S.   Elevated immunoglobulin E against recombinant Brugia malayi gamma-glutamyl transpeptidase in patients with bancroftian filariasis: association with tropical pulmonary eosinophilia or putative immunity. Infect Immun. 2003 Feb;71(2):747-53.

7209.   Palacio AM, Lichstein DM, Vaamonde CA, Tamariz L.   Parasitic chyluria. South Med J. 2003 Jan;96(1):110-1.

7210.   Rajendran R, Sunish IP, Mani TR.   Mass treatment of filariasis in New Guinea. N Engl J Med. 2003 Mar 20;348(12):1179-81

7211.   Winter AD, Myllyharju J, Page AP.  A hypodermally expressed prolyl 4-hydroxylase from the filarial nematode Brugia malayi is soluble and active in the absence of protein disulfide isomerase. J Biol Chem. 2003 Jan 24;278(4):2554-62.


7212.   Addiss DG.  Mass treatment of filariasis in New Guinea. N Engl J Med. 2003 Mar 20;348(12):1179-81

7213.   Babu BV, Satyanarayana K.  Healthcare workers' knowledge of lymphatic filariasis and its control in an endemic area of Eastern India: implications on control programme. Trop Doct. 2003 Jan;33(1):41-2.

7214.   Burnham G.  The right word. Lancet. 2003 Feb 8;361(9356):456.

7215.   Guevara AG, Vieira JC, Lilley BG, Lopez A, Vieira N, Rumbea J, Collins R, Katholi CR, Unnasch TR.   Entomological evaluation by pool screen polymerase chain reaction of Onchocerca volvulus transmission in Ecuador following mass Mectizan distribution. Am J Trop Med Hyg. 2003 Feb;68(2):222-7.

7216.   Hoerauf A, Buttner DW, Adjei O, Pearlman E.  Onchocerciasis. BMJ. 2003 Jan 25;326(7382):207-10.

7217.   Kerr C.  Success for river blindness control campaign. Lancet Infect Dis. 2003 Feb;3(2):65.

7218.   Nanda B, Krishnamoorthy K.  Treatment seeking behaviour and costs due to acute and chronic forms of lymphatic filariasis in urban areas in south India. Trop Med Int Health. 2003 Jan;8(1):56-9.

7219. Rajendran R, Sunish IP, Mani TR.  Mass treatment of filariasis in New Guinea. N Engl J Med. 2003 Mar 20;348(12):1179-81

October 2003

7938.         De Silva NR, Pathmeswaran A, Fernando SD, Weerasinghe CR, Selvaratnam RR, Padmasiri EA, Montresor A. Impact of mass chemotherapy for the control of filariasis on geohelminth infections in Sri Lanka. Ann Trop Med Parasitol. 2003 Jun;97(4):421-5. 

7939.      Hoerauf A, Mand S, Volkmann L, Buttner M, Marfo-Debrekyei Y, Taylor M, Adjei O, Buttner DW. Doxycycline in the treatment of human onchocerciasis: Kinetics of Wolbachia endobacteria reduction and of inhibition of embryogenesis in female Onchocerca worms. Microbes Infect. 2003 Apr;5(4):261-73. 

7940.      Natarajan R. Another case of human subconjunctival infection by Macacanema formosana. Arch Ophthalmol. 2003 Apr;121(4):584-5. 

7941.      Penzer R. Lymphoedema. Nurs Stand. 2003 May 14-20;17(35):45-51; quiz 52, 55. 

7942.      Yoshino N, Hisayoshi T, Sasaki T, Yamauchi S, Oaki Y, Hino M. Human pulmonary dirofilariasis in a patient whose clinical condition altered during follow-up. Jpn J Thorac Cardiovasc Surg. 2003 May;51(5):211-3. 


7943.      Stanley P, Stein PE. BmSPN2, a serpin secreted by the filarial nematode Brugia malayi, does not inhibit human neutrophil proteinases but plays a noninhibitory role. Biochemistry. 2003 May 27;42(20):6241-8. 


7944.      Babu BV, Nayak AN.  Footcare among lymphoedema patients attending a filariasis clinic in South India: a study of knowledge and practice. Ann Trop Med Parasitol. 2003 Apr;97(3):321-4.

7945.      Babu BV, Satyanarayana K.  Factors responsible for coverage and compliance in mass drug administration during the programme to eliminate lymphatic filariasis in the East Godavari District, South India. Trop Doct. 2003 Apr;33(2):79-82.

7946.      McLaughlin SI, Radday J, Michel MC, Addiss DG, Beach MJ, Lammie PJ, Lammie J, Rheingans R, Lafontant J.   Frequency, severity, and costs of adverse reactions following mass treatment for lymphatic filariasis using diethylcarbamazine and albendazole in Leogane, Haiti, 2000. Am J Trop Med Hyg. 2003 May;68(5):568-73.

7947.      Penzer R.  Lymphoedema. Nurs Stand. 2003 May 14-20;17(35):45-51; quiz 52, 55.

7948.    Post RJ, Flook PK, Millest AL, Cheke RA, McCall PJ, Wilson MD, Mustapha M, Somiari S, Davies JB, Mank RA, Geenen P, Enyong P, Sima A, Mas J.  Cytotaxonomy, morphology and molecular systematics of the Bioko form of Simulium yahense (Diptera: Simuliidae). Bull Entomol Res. 2003 Apr;93(2):145-57.

7949.      Sunish IP, Rajendran R, Mani TR, Gajanana A, Reuben R, Satyanarayana K.  Long-term population migration: an important aspect to be considered during mass drug administration for elimination of lymphatic filariasis. Trop Med Int Health. 2003 Apr;8(4):316-21.

7950.      Taylor MJ.  Wolbachia in the Inflammatory Pathogenesis of Human Filariasis. Ann N Y Acad Sci. 2003 Jun;990:444-449. 

7951.  Volkmann L, Fischer K, Taylor M, Hoerauf A.  Antibiotic therapy in murine filariasis (Litomosoides sigmodontis): comparative effects of doxycycline and rifampicin on Wolbachia and filarial viability.Trop Med Int Health. 2003 May;8(5):392-401.


Click Here for Abstract

Back To Content Page